siRNA
SARS-CoV-2 Protein Interaction Study Reveals Key Proliferation Pathways, Possible Drug Targets
Premium
The study compared SARS-CoV-2 to SARS-CoV-1 and MERS to find viral commonalities, and combined the analyses with real-world clinical data to suggest treatments.
The company's platform is based on nucleotide deamination, a process that occurs naturally in cells and doesn't create a permanent edit in the genome.
Cowen Initiates Coverage of Horizon Discovery at Outperform
The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.
With optimization work currently being done with beta testers, the company is negotiating with companies to provide their siRNA library content on its plates.
Title: RNA Interference Modulators of Hedgehog Signaling and Uses Thereof
Patent Number: 8,802,639
Filed: March 24, 2005
Jun 26, 2014
Jan 9, 2014
Dec 12, 2013
Oct 31, 2013
Oct 3, 2013
Jun 20, 2013
Apr 12, 2012
Mar 1, 2012
Jan 26, 2012
Nov 17, 2011
Nov 10, 2011
Nov 10, 2011